Mesa Laboratories, Inc. MLI.F Stock
Mesa Laboratories, Inc. Price Chart
Mesa Laboratories, Inc. MLI.F Financial and Trading Overview
Mesa Laboratories, Inc. stock price | 96.5 EUR |
Previous Close | 124 EUR |
Open | 121 EUR |
Bid | 121 EUR x N/A |
Ask | 124 EUR x N/A |
Day's Range | 121 - 121 EUR |
52 Week Range | 118 - 208 EUR |
Volume | 30 EUR |
Avg. Volume | 0 EUR |
Market Cap | 649.77M EUR |
Beta (5Y Monthly) | 0.736971 |
PE Ratio (TTM) | 711.7647 |
EPS (TTM) | 0.15 EUR |
Forward Dividend & Yield | 0.6 (0.47%) |
Ex-Dividend Date | May 30, 2023 |
1y Target Est | 315 EUR |
MLI.F Valuation Measures
Enterprise Value | 840.97M EUR |
Trailing P/E | 711.7647 |
Forward P/E | 55.25114 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.9658809 |
Price/Book (mrq) | 1.6511784 |
Enterprise Value/Revenue | 3.839 |
Enterprise Value/EBITDA | 22.641 |
Trading Information
Mesa Laboratories, Inc. Stock Price History
Beta (5Y Monthly) | 0.736971 |
52-Week Change | -26.16% |
S&P500 52-Week Change | 20.43% |
52 Week High | 208 EUR |
52 Week Low | 118 EUR |
50-Day Moving Average | 144.68 EUR |
200-Day Moving Average | 154.75 EUR |
MLI.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 5.37M |
Float | 5.14M |
Short Ratio | N/A |
% Held by Insiders | 5.72% |
% Held by Institutions | 97.01% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.64 |
Trailing Annual Dividend Yield | 0.51% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 3.7647 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 0.42% |
Operating Margin (ttm) | 1.51% |
Gross Margin | 61.02% |
EBITDA Margin | 16.95% |
Management Effectiveness
Return on Assets (ttm) | 0.30% |
Return on Equity (ttm) | 0.23% |
Income Statement
Revenue (ttm) | 219.08M EUR |
Revenue Per Share (ttm) | 41.17 EUR |
Quarterly Revenue Growth (yoy) | -5.60% |
Gross Profit (ttm) | N/A |
EBITDA | 37.14M EUR |
Net Income Avi to Common (ttm) | 930K EUR |
Diluted EPS (ttm) | 0.17 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 32.91M EUR |
Total Cash Per Share (mrq) | 6.13 EUR |
Total Debt (mrq) | 191.89M EUR |
Total Debt/Equity (mrq) | 48.77 EUR |
Current Ratio (mrq) | 2.744 |
Book Value Per Share (mrq) | 73.281 |
Cash Flow Statement
Operating Cash Flow (ttm) | 27.98M EUR |
Levered Free Cash Flow (ttm) | 25.02M EUR |
Profile of Mesa Laboratories, Inc.
Country | Germany |
State | CO |
City | Lakewood |
Address | 12100 West Sixth Avenue |
ZIP | 80228 |
Phone | 303 987 8000 |
Website | https://www.mesalabs.com |
Industry | Scientific & Technical Instruments |
Sector(s) | Technology |
Full Time Employees | 698 |
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enable customers to automate chemical synthesis of peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, and humidity for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Q&A For Mesa Laboratories, Inc. Stock
What is a current MLI.F stock price?
Mesa Laboratories, Inc. MLI.F stock price today per share is 96.5 EUR.
How to purchase Mesa Laboratories, Inc. stock?
You can buy MLI.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mesa Laboratories, Inc.?
The stock symbol or ticker of Mesa Laboratories, Inc. is MLI.F.
Which industry does the Mesa Laboratories, Inc. company belong to?
The Mesa Laboratories, Inc. industry is Scientific & Technical Instruments.
How many shares does Mesa Laboratories, Inc. have in circulation?
The max supply of Mesa Laboratories, Inc. shares is 5.47M.
What is Mesa Laboratories, Inc. Price to Earnings Ratio (PE Ratio)?
Mesa Laboratories, Inc. PE Ratio is 643.33330000 now.
What was Mesa Laboratories, Inc. earnings per share over the trailing 12 months (TTM)?
Mesa Laboratories, Inc. EPS is 0.15 EUR over the trailing 12 months.
Which sector does the Mesa Laboratories, Inc. company belong to?
The Mesa Laboratories, Inc. sector is Technology.